Immutep(IMMP) - 2025 FY - Earnings Call Presentation

Annual General Meeting 2025 (ASX:IMM, NASDAQ:IMMP) 1 Empowering the immune system to fight cancer and autoimmune disease For personal use only Forward Looking Statements The purpose of the presentation is to provide an update of the business of Immutep Limited ACN 009 237 889 (ASX:IMM; NASDAQ:IMMP). These slides have been prepared as a presentation aid only and the information they contain may require further explanation and/or clarification. Accordingly, these slides and the information they contain should ...